Astral Foods (ARL) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
13 Jan, 2026Executive summary
Revenue increased 6.4% to R20.5 billion, with a dramatic turnaround from a prior year loss of R620 million to an operating profit of R1,125 million, driven by the Poultry Division's recovery and improved operational efficiencies.
Headline earnings per share rose 245% to 1,920 cents, and a final dividend of 520 cents per share was declared.
All debt was cleared, supported by a cash inflow of R1.1 billion and normalized capital expenditure.
Broiler margins improved to 1.3% from negative last year, though retail competition and constrained consumer spending keep margins thin.
No bird flu incidents since October 2023, with broiler performance indicators surpassing historical levels.
Financial highlights
Revenue rose to R20,480 million from R19,251 million year-over-year; operating profit rebounded to R1,125 million from a loss of R621 million.
Net profit for the period was R753 million, compared to a loss of R512 million in the prior year.
Headline earnings per share improved to 1,920 cents, up 245% year-over-year.
Net cash inflow of R1,095 million enabled debt clearance; closing cash balance at R13 million.
Capital expenditure normalized at R275 million, focusing on essential infrastructure and efficiency.
Outlook and guidance
Bird flu remains a significant risk, with slow progress on vaccination approval for broiler breeding stock.
Water supply disruptions, infrastructure challenges, and constrained consumer spending continue to impact market conditions.
Interest rate cuts and retirement reforms may boost consumer spending in 2025.
Spare processing capacity of 600,000 birds per week positions the group for volume growth without additional capex.
Revised capex program supports cash flow and cost efficiency projects.
Latest events from Astral Foods
- EPS and HEPS are set to surge over 365% and 435% respectively for the interim period.ARL
Trading update18 Mar 2026 - Double-digit revenue and profit growth, margin gains, but risks from bird flu and trade persist.ARL
H2 202520 Nov 2025 - Operating profit halved despite revenue growth, with poultry margins under severe pressure.ARL
H1 202520 Nov 2025